Taysha Gene Therapies (TSHA) Debt Ratio (2020 - 2026)
Taysha Gene Therapies (TSHA) posted Debt Ratio of 0.16 for Q1 2026, up 11.69% sequentially from 0.15 in Q4 2025, and down 46.87% YoY from 0.31 in Q1 2025.
Taysha Gene Therapies (TSHA) Debt Ratio (2020 - 2026) Analysis & Trends
Taysha Gene Therapies has reported Debt Ratio for 7 years, with the latest figure at 0.16 in Q1 2026.
- Quarterly Debt Ratio fell 46.87% year-over-year to 0.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.16 (down 46.87% YoY) and the FY2025 annual result came in at 0.15, down 46.74% from the prior year.
- Debt Ratio improved to 0.16 in Q1 2026 per TSHA's latest filing, from 0.15 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.47 in Q2 2023 and troughed at 0.12 in Q2 2025.
- A 5-year average of 0.25 and a median of 0.24 in 2024 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio surged 193.69% in 2022, then slumped 59.86% in 2024.
- Over 5 years, Debt Ratio stood at 0.3 in 2022, then dropped by 22.0% to 0.23 in 2023, then grew by 16.84% to 0.27 in 2024, then plunged by 46.74% to 0.15 in 2025, then climbed by 11.69% to 0.16 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.16, 0.15, and 0.16 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Taysha Gene Therapies | 1.94 Bn | 1.94 Bn | - | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.10 |
| Mar 31, 2026 | 0.16 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.16 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.24 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.26 |
| Dec 31, 2023 | 0.23 |
| Sep 30, 2023 | 0.20 |
| Jun 30, 2023 | 0.47 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.30 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.12 |